You are here

primary immunodeficiency

FDA approves Grifols’ Xembify to treat primary immunodeficiencies

Pharmaceutical Business Review

Sun, 07/7/19 - 11:11 am

primary immunodeficiency

ADMA Biologics returning Bivigam to market after 3-year absence

Fierce Pharma

Mon, 05/13/19 - 08:26 pm

primary immunodeficiency

Baxter prepping for HyQvia launch with spinoff's success on the line

Fierce Pharma

Mon, 10/20/14 - 11:36 am

Baxter International

primary immunodeficiency

Baxter provides U.S. regulatory update on HyQvia

The Fly on the Wall

Wed, 05/21/14 - 10:13 am

Baxter International

primary immunodeficiency